House Speaker Mike Johnson confronts a fractured Republican conference upon lawmakers' return to Washington, with hardline members demanding contentious policy riders in exchange for votes to end the government shutdown.
In an exclusive interview, GeneDx CEO Katherine Stueland details how rapid genomic testing is transforming pediatric care, slashing diagnosis times from years to days and building a data-driven bridge to future therapies.
Fabrinet's fiscal Q2 2026 results smashed expectations, fueled by explosive growth in data center interconnect modules and a breakout performance in high-performance computing. The manufacturing services provider raises guidance, signaling strong momentum across its key markets.
Simon Property Group reported robust fourth-quarter results, driven by record funds from operations and resilient leasing demand. The retail REIT giant is steering a multi-billion dollar redevelopment strategy while returning significant capital to shareholders, even as it navigates a cautious outlook for 2026.
Rambus reported record annual revenue and earnings for fiscal 2025, fueled by strong DDR5 adoption and AI-driven data center growth. While a one-time supply chain issue is expected to pressure Q1 2026 product revenue, management expressed confidence in a swift recovery and sustained long-term momentum.
Palantir Technologies' fourth-quarter earnings reveal a seismic shift, with U.S. commercial revenue for its AI Platform soaring 137%. The data analytics firm posted its highest growth rate as a public company, powered by massive government contracts and enterprise adoption, while setting aggressive targets for the year ahead.
Elon Musk consolidates his AI and aerospace ambitions as SpaceX purchases his controversial AI firm xAI, aiming to build orbital data centers and scale AI using space-based solar power, amidst scrutiny over xAI's past products.
The U.S. dollar climbed to a one-week high, buoyed by unexpectedly strong manufacturing activity and hawkish-leaning Federal Reserve commentary. The rally pressured major currency pairs and sent precious metals tumbling, as markets reassessed the timeline for potential interest rate cuts.
Alphabet's autonomous vehicle unit Waymo is reportedly in talks to raise approximately $16 billion in a new financing round, which would value the company close to $110 billion. The move comes as the robotaxi pioneer faces heightened regulatory and public scrutiny following recent incidents involving its vehicles.
Palantir Technologies' stock gained momentum Monday following an upgrade by William Blair, a move vindicated after hours by a strong Q4 earnings report that exceeded forecasts and set robust guidance for 2026.
ExxonMobil capped 2025 with its highest annual oil and gas output in over four decades while returning historic cash to shareholders, setting the stage for a pivotal year as it balances traditional strength with energy transition investments.
Despite a challenging year for its stock price, a deep dive into Hess Midstream's financials suggests the midstream operator may be significantly undervalued. Our analysis examines the cash flow story behind the recent share price weakness and what it means for investors.
McDonald's is launching a high-end caviar pairing for Valentine's Day and introducing spicy menu items in Canada, signaling a dual strategy to engage customers through both luxury experiences and bold flavors.
Identity management giant Okta is responding to a significant phishing campaign targeting over 100 enterprise customers' single sign-on credentials, while simultaneously naming Dan Mountstephen to lead its Asia-Pacific and Japan expansion efforts.
Revvity shares have faced significant pressure, down over 13% in the past year. A deep dive into its valuation reveals a stark contradiction: while a cash flow model suggests the stock is undervalued, its price-to-earnings multiple tells a different story. We examine the numbers and what they mean for investors.
Merck & Co. is laying the groundwork for its future in oncology beyond Keytruda, announcing a strategic investment in biotech Eikon Therapeutics and a major collaboration with diagnostic leader Guardant Health. The moves signal a targeted, partnership-driven strategy to bolster its pipeline and diagnostics capabilities in the competitive cancer therapy market.
Gold and silver prices have soared over the past year, but recent volatility has many consumers and investors weighing whether to cash in on jewelry holdings or hold firm.
While the fried chicken segment continues to dominate fast-food traffic, Buffalo-based Hen House Nashville Hot Chicken has filed for bankruptcy protection, highlighting the uneven fortunes within the popular sector.
The storied outdoor apparel brand Eddie Bauer is set to close all its physical stores across North America and file for Chapter 11 bankruptcy, marking a pivotal moment for a century-old retailer struggling to adapt in a rapidly changing market.
Investment firm Hussman Strategic Advisors has liquidated its entire stake in TG Therapeutics, a move that comes as the biotech's stock lags behind broader market gains despite reporting strong revenue growth for its flagship product.
